Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS

Virology

Volumn 241, Issue 2, 1998, Pages 260-268

  Green, Kathy A ^a   Noelle, Randolph J ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CONCANAVALIN A; GLYCOPROTEIN GP 39; MITOGENIC AGENT; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENETIC SUSCEPTIBILITY; HYPERGAMMAGLOBULINEMIA; LYMPHADENOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RODENT DISEASE; SPLENOMEGALY; VIRUS ISOLATION;

ANIMALIA; MURINAE; RNA VIRUSES; RODENTIA; UNIDENTIFIED RETROVIRUS;

EID: 0032519890     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8970     Document Type: Article

References (42)

1. Allen R.C., Armitage R. J., Conley M. E., Rosenblatt H., Jenkins N. A., Copeland N. G., Bedell M. A., Edelhoff S., Disteche J., Simoneaux D. K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:1993;990.
2. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Madcuff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80.
3. Aziz D. C., Hanna Z., Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukemia virus. Nature (London). 338:19889;505.
4. Buller R. M. L., Yetter R. A., Fredrickson T. N., Morse H.C. III. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J. Virol. 61:1987;383.
5. Butcher E. C., Rouse R. V., Coffman R. L., Nottenberg C. N., Hardy R. R., Weissman I. Surface phenotype of Peyer's patch germinal center cells: Implications for the role of germinal centers in B cell differentiation. J. Immunol. 129:1982;2698.
6. Cerny A., Hugin A. W., Hardy R. R., Hayakawa K., Zinkernagel R. M., Makino M., Morse H. C. III. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:1990;315.
7. Chattopadhyay S. K., Morse H.C. III, Makino M., Ruscetti S. K., Hartley J. W. A defective virus is associated with induction of a murine retrovirus-induced immunodeficiency syndrome, MAIDS. Proc. Natl. Acad. Sci. USA. 86:1989;3862.
8. Coico R. F., Bhogal B. S., Thorbecke G. J. Relationship of germinal centers in lymphoid tissue to immunologic memory. VI. Transfer of B cell memory with lymph node cells fractionated according to their receptors for peanut agglutinin. J. Immunol. 131:1983;2254.
9. Durie F. H., Fava R. A., Foy T. M., Aruffo A., Ledbetter J. A., Noelle R. J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1993;1328.
10. Durie F. H., Foy T. M., Noelle R. J. The role of CD40 and its ligand (gp39) in peripheral and central T cell tolerance and its contribution to autoimmune disease. Res. Immunol. 45:1994;163.
11. Early G. S., Zhao W., Burns C. M. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. J. Immunol. 157:1996;3159.
12. Foy T. M., Laman J. D., Ledbetter J. A., Aruffo A., Claassen E., Noelle R. J. Gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:1994;157.
13. Gerritse K., Laman J. D., Noelle R. J., Aruffo A., Ledbetter J. A., Boersma W. J. A., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 93:1996;2499.
14. +. J. Virol. 68:1994;5819.
15. Gras G, Legendre C., Krzysiek R., Dormont D., Galanaud P., Richard Y. CD40/CD40L interactions and cytokines regulate HIV replication in B cellsin vitro. Virology. 220:1996;309.
16. Green K. A., Crassi K. M., Laman J. D., Schoneveld A., Strawbridge R. R., Foy T. M., Noelle R. J., Green W. R. Antibody to the Ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J. Virol. 70. 1996;2569.
17. Green W. R., Green K. A., Crassi K. M. Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: A measure of protection against LP-BM5 retrovirus-induced immunodeficiency. J. Virol. 68:1994;4679.
18. Han S., Hathcock K., Zheng B., Kepler T. B., Hodes R., Kelsoe G. Cellular interaction in germinal centers, Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:1995;556.
19. Hartley J. W., Fredrickson T. N., Yetter R. A., Makino M., Morse H. C. III. Retrovirus-induced murine acquired immunodeficiency syndrome: Natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1989;1223.
20. Huang M., Simard C., Jolicoeur P. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science. 246:1989;1614.
21. Huang M., Simard C., Kay D. G., Jolicoeur P. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:1991;6562.
22. Huang M., Takac M., Kozak C., Jolicoeur P. The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells. J. Virol. 69:1995;4069.
23. Jolicoeur J. P. Murine acquired immunodeficiency syndrome (MAIDS): An animal model to study AIDS pathogenesis. FASEB. 5:1991;2398.
24. Kim W. K., Tang Y., Kenny J. J., Longo D. L., Morse H. C. III. In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J. Virol. 68:1994;6767.
25. Klinken S. P., Fredrickson T. N., Hartley J. W., Yetter R. A., Morse H.C. III. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140:1988;1123.
26. Klinman D. M., Morse H. C. III. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1989;1144.
27. Kubo Y., Kakimi K., Higo K., Kobayashi H., Ono T., Iwama Y., Kuribayashi K., Hiai H., Adachi A., Ishimoto A. Possible origin of murine AIDS (MAIDS) virus: Conversion of an endogenous retroviral p12 gag sequence to a MAIDS-inducing sequence by frameshift mutations. J. Virol. 70:1996;6405.
28. Laman J. D., Claassen E., Noelle R. J. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:1996;59.
29. Legrand E., Daculsi R., Duplan J. F. Characteristics of the cell populations involved in extrathymic lymphosarcoma induced in C57BL/6 mice by RadLV-RS. Leukemia Res. 5:1981;223.
30. Morse H. C. III, Chattopadhyay S. K., Makino M., Fredrickson T. N., Ambros H. W., Hartley J. W. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS. 6:1992;607.
31. Morse H. C. III, Yetter R. A., Via C. S., Hardy R. R., Cerny A., Hayakawa K., Hugin A. W., Miller M. W., Homes K. L., Shearer G. M. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J. Immunol. 143:1989;844.
32. Mosier D. E., Yetter R. A., Morse H. C. III. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1987;1737.
33. Mosier D. E., Yetter R. A., Morse H. C. III. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:1985;766.
34. Nieuwenhuis P., Kroese F. G. M., Opstelten D., Seijen H. G. De novo germinal center formation. Immunol. Rev. 126:1992;77.
35. Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A., Aruffo A. A novel ligand on activated T helper cells binds CD40 and transduces the signal for the cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89:1992;6550.
36. Pattengale P. K., Taylor C. R., Twomey P., Hill S., Jonasson J., Beardsley T., Haas M. Immunopathology of B cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am. J. Pathol. 107:1982;362.
37. Pinchuk L. M., Polacino P. S., Agy M. B., Klaus S. J., Clark E. A. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity. 1:1994;317.
38. Ranheim E. A., Kipps T. J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:1993;925.
39. Rose M. L., Birbeck M. S. C., Wallis V. J., Forrester J. A., Davies A. J. S. Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature. 284:1980;364.
40. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 42:1970;1136.
41. Uckun F. M., Schieven G. L., Dibirdik I., Chandan L. M., Tuel A. L., Ledbetter J. A. Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 266:1991;17478.
42. +. J. Exp. Med. 168:1988;623.